Results 181 to 190 of about 370,724 (274)
An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond. [PDF]
McIntyre P +8 more
europepmc +1 more source
Introducing Rubella Vaccine into the National Immunisation Schedule
openaire +2 more sources
Full immunization for age was achieved by 71.7% of children. Caregiver education, health facility delivery, rural residence, regular community immunization services, and positive caregiver attitudes significantly increased coverage, highlighting the need to strengthen primary health care services, health education, and equitable access to routine ...
Aruwa Simon Ayigu +3 more
wiley +1 more source
Health worker practices and challenges surrounding routine immunisation service delivery of measles-containing vaccine: a cross-sectional assessment of health facilities in Oromia region, Ethiopia - 2021. [PDF]
Gelmessa TD +22 more
europepmc +1 more source
A Secure IoT–Blockchain Framework for Vaccine Cold‐Chain Monitoring With Predictive Analytics
This proof‐of‐concept framework integrates IoT sensing, secure MQTT/TLS communication, SHA‐256 hash verification, permissioned blockchain provenance tracking, and predictive analytics for vaccine cold‐chain monitoring. Evaluation using 26,674 logistics observations shows feasible secure telemetry management and short‐term temperature forecasting to ...
Lakshmanan Muthusamy +3 more
wiley +1 more source
Turning the Tide on Cervical Cancer in India. [PDF]
Suvvari TK.
europepmc +1 more source
ABSTRACT Introduction Equity is recognised in the decision‐making within Australian health technology assessment (HTA), although limited studies describe how these considerations are operationalised in practice. We aimed to explore the experiences and views of a range of HTA actors, to understand how equity is considered in HTA processes.
Sheridan Rodda +4 more
wiley +1 more source
National immunisation recommendations: why country-specific evidence and context matter. [PDF]
Schaefer R +3 more
europepmc +1 more source
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Matthias Tenbusch +15 more
wiley +1 more source
ABSTRACT Background Survivorship care plans (SCPs) summarize cancer treatment and guide risk‐based follow‐up for cancer survivors, yet remain difficult to create, share, and use. Stakeholder perspectives are needed to inform usable approaches.
Molly S. Talman +4 more
wiley +1 more source

